Virgin Galactic Launches First Commercial Flight to Space
A team of Italian researchers reached the edge of space Thursday morning, flying aboard Virgin Galactic’s rocket-powered plane as the company prepares for monthly commercial flights.
The flight launched from Spaceport America in the New Mexico desert, with two Italian Air Force officers and an engineer with the National Research Council of Italy focusing on a series of microgravity experiments during their few minutes of weightless.
One wore a special suit that measured biometric data and physiological responses while another conducted tests using sensors to track heart rate, brain function and other metrics while in microgravity. The third studied how certain liquids and solids mix in that very weak gravity.
Virgin Galactic livestreamed the flight on its website, showing the moment when the ship released from its carrier plane and the rocket was ignited. The entire trip took about 90 minutes, with the plane's touchdown on the runway prompting cheers and claps by Virgin Galactic staff.
With the ship’s copilots, it marked the most Italians in space at the same time. Col. Walter Villadei, a space engineer with the Italian Air Force, celebrated by unfolding an Italian flag while weightless.
Next up for Virgin Galactic will be the first of hundreds of ticket holders, many who have been waiting years for their chance at weightlessness and to see the curvature of the Earth. Those commercial flights are expected to begin in August and will be scheduled monthly, the space tourism company said.
Virgin Galactic has been working for years to send paying passengers on short space trips and in 2021 finally won the federal government’s approval. The company completed its final test fight in May.
The Italian research flight was initially scheduled for the fall of 2021 but Virgin Galactic at the time said it was forced to push back its timeline due to a potential defect in a component used in its flight control system. Then the company spent months upgrading its rocket ship before resuming testing in early 2023.
After reaching an altitude of nearly 50,000 feet (15,000 meters), Virgin Galactic’s space plane is released from a carrier aircraft and drops for a moment before igniting its rocket motor. The rocket shuts off once it reaches space, leaving passengers weight before the ship then glides back to the runway at Spaceport America.
Virgin Galactic has sold about 800 tickets over the past decade, with the initial batch going for $200,000 each. Tickets now cost $450,000 per person.
The company said early fliers have already received their seat assignments.
Healthcare workforce management platform ShiftMed
recently announced a $45 million funding round.
The company's platform connects nurses and healthcare professionals to hospitals and other healthcare providers.
ShiftMed's new funding comes amid widespread labor shortages in the healthcare sector. The company's CEO Todd Walrath joins Cheddar News' Closing Bell to discuss.
Universities like UCLA, Yale, and Duke have announced they're implementing remote learning amid the COVID omicron variant surge, despite President Biden recommending that K-12 schools should continue in-person education. Jared C. Bass, senior director for Higher Education at American Progress, joined Cheddar to break down what institutions of higher education might be considering differently. "I think some universities are allowing periods of a bit of a respite to allow students to get testing and make sure when they do return back to campus that they're healthy," he noted.
Supply chain issues have become one of the biggest roadblocks for the U.S. EV market, with production woes likely to stunt the industry's growth in 2022. Rich Steinberg, electric vehicle expert and industry advisor, told Cheddar that the Biden administration investing in domestic mining for essential minerals used in battery manufacturing — such as lithium — could help alleviate the bottlenecks. "Some of those same materials are available domestically, they just haven't been prioritized," he said, noting the paradox between green tech and "dirty" mining. "The good news is that there are ways to extract those materials cleanly."
Hyperfine, the pioneer of the very first FDA-approved portable MRI device, made its public debut on the Nasdaq via a SPAC merger. CEO Dave Scott joined Cheddar's "Opening Bell" to discuss the IPO launch, the company's valuation at $580 million, and the impact of its machine called Swoop. "We can roll an MRI system, our MRI Swoop system, right into the room where you are, right up to your patient bedside, and scan you right there and get an image in less than an hour," he explained.
Dr. Rob Davidson, Executive Director of the Committee to Protect Health Care and an ER Physician in West Michigan, joins Cheddar News to break down the expectations of Pfizer's new COVID-19 treatment pill.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
